Raju N, Kramer KJ, Cavallaro M, Diotti RA, Shiakol. Multiplexed Antibody Sequencing and Profiling of the Human Hemagglutinin-specific Memory B Cell Response following Influenza Vaccination. J Immunol. 2024 Oct 23:ji2400326. Abstract submitted by kickingbird at 45 minute(s) ago from J Immunol. 2024 Oct 23:ji2400326 Influenza virus is a highly contagious respiratory pathogen causing between 9.4 and 41 million infections per year in the United States in the last decade. Annual vaccination is recommended by the World ... Odin M, Schmeisser F, Soto J, Weir JP. A Rapid Virus-Free Method for Producing Influenza HA Immunogen Needed for Preparation of Influenza Vaccine Potency Antisera Reagents. Influenza Other Respir Viruses. 2024 Oct;18(10):e7. Abstract submitted by kickingbird at 46 minute(s) ago from Influenza Other Respir Viruses. 2024 Oct;18(10):e7 Background: The potency of inactivated and recombinant influenza vaccines is measured using the single-radial immunodiffusion (SRID) assay. The strain-specific antigen and antibody potency reagents required ... Lane MC, Luke CJ, Bresee J, Dugan VG, Post DJ, Sch. Meeting Report: Controlled Human Influenza Virus Infection Model Studies: Current Status and Future Directions for Innovation. Influenza Other Respir Viruses. 2024 Oct;18(10):e1. Abstract submitted by kickingbird at 47 minute(s) ago from Influenza Other Respir Viruses. 2024 Oct;18(10):e1 On November 13-14, 2023, the National Institute of Allergy and Infectious Diseases (NIAID) in partnership with the Task Force for Global Health, Flu Lab, the Canadian Institutes of Health Research, and ... USCDC. Interim Guidance for Employers to Reduce the Risk of Novel Influenza A for People Working with or Exposed to Animals. USCDC. Abstract submitted by kickingbird at 50 minute(s) ago from USCDC Human infections with novel influenza A viruses (such as H5N1 Bird Flu) can happen when enough virus gets into a person's eyes, nose, or mouth, or is inhaled. This can happen when virus is in the air (in ... ?al??kan, D. M., Kumar, S., Hinse, S., Schughart,. Molecular characterisation of influenza B virus from the 2017/18 season in primary models of the human lung reveals improved adaptation to the lower respiratory tract. Emerging Microbes & Infections. Abstract submitted by kickingbird at 2 days ago from Emerging Microbes & Infections The 2017/18 influenza season was characterized by unusual high numbers of severe infections and hospitalizations. Instead of influenza A viruses, this season was dominated by infections with influenza ... | |